Zhejiang Jiuzhou Pharmaceutical Hits Day High with Strong 3.66% Gain

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has experienced a notable uptick in its stock performance, gaining 3.66% on March 24, 2026. The stock reached an intraday high of CNY 15.85, reflecting a positive shift in market sentiment. In terms of performance metrics, the company has shown a year-to-date decline of 11.51%, contrasting with the China Shanghai Composite's decrease of 2.21%. Over the past year, Zhejiang Jiuzhou has delivered a return of 15.62%, slightly outperforming the broader index, which recorded a 15.17% gain. However, the stock has faced challenges over longer periods, with a significant drop of 57.06% over the past three years. Financially, Zhejiang Jiuzhou maintains a market capitalization of CNY 15,762 million and a price-to-earnings ratio of 26.00. The company also boasts a return on equity of 8.26% and a dividend yield of 2.85%, indicating a solid valuation in the pharmaceuticals and biotechnology sector. As the stock continues to navigate market dynamics, its recent performance highlights its resilience amid broader market trends.